Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decline in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 18,768 shares, a decrease of 78.8% from the August 15th total of 88,674 shares. Based on an average daily volume of 183,620 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.8% of the company’s shares are sold short.

Arcadia Biosciences Stock Performance

Shares of NASDAQ:RKDA opened at $0.45 on Friday. The stock has a 50-day simple moving average of $0.59 and a 200-day simple moving average of $1.02. The stock has a market capitalization of $1.08 million, a P/E ratio of -0.10 and a beta of 0.53. Arcadia Biosciences has a 1 year low of $0.38 and a 1 year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last posted its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The business had revenue of $1.44 million during the quarter, compared to analysts’ expectations of $1.90 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.